The estimated Net Worth of John F Ginascol is at least $17.4 millió dollars as of 28 February 2023. Mr Ginascol owns over 943 units of Abbott Laboratories stock worth over $13,803,108 and over the last 5 years he sold ABT stock worth over $1,928,887. In addition, he makes $1,678,298 as Exec. VP of Core Diagnostics at Abbott Laboratories.
Mr has made over 8 trades of the Abbott Laboratories stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 943 units of ABT stock worth $94,960 on 28 February 2023.
The largest trade he's ever made was exercising 72,098 units of Abbott Laboratories stock on 1 September 2020 worth over $3,111,750. On average, Mr trades about 12,517 units every 69 days since 2019. As of 28 February 2023 he still owns at least 118,380 units of Abbott Laboratories stock.
You can see the complete history of Mr Ginascol stock trades at the bottom of the page.
John F. Ginascol is the Exec. VP of Core Diagnostics at Abbott Laboratories.
As the Exec. VP of Core Diagnostics of Abbott Laboratories, the total compensation of Mr Ginascol at Abbott Laboratories is $1,678,298. There are 11 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of $27,802,800.
Mr Ginascol is 62, he's been the Exec. VP of Core Diagnostics of Abbott Laboratories since . There are 11 older and 30 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
John's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez és Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: